MAT for Opioid Use Disorders

Northwest ATTC (2012-2017)

03/21/2017

Educational Event: Course Overview Harmful opioid use, including heroin, oxycodone and hydrocodone, and opioid use disorders remain a critical national public health concern. There are several FDA-approved medications to assist in the treatment of opioid use disorders and each of these medications offers individuals a somewhat different approach. This training will focus on enhancing understanding of the role of methadone, buprenorphine, and oral and extended-release naltrexone in treating opioid use disorders. The training will provide an overview of the research related to the use of these medications for both adults and young adults, as well as the practical issues related to providing coordinated care for individuals utilizing these medications as a treatment intervention. This training will also provide information about the use of the naloxone (Narcan) in the treatment of opioid overdose and as an overdose prevention tool.

Registration Fee:
Address:
Guest House Red Lion
510 Kelso Drive
Kelso, Washington 98626
For more information, contact:
Anya Ludwig
Phone: 5034948255
Email: ludwig@ohsu.edu
Registration
https://www3.thedatabank.com/dpg/423/mtglistproc.asp?formid=nwmeet&caleventid=31999
Collaborators
Washington Department of Social and Health Services/Division of Behavioral Health and Recovery
Attachments
3.21 MAT OUD flyer
HANDOUT
NOTE: To view Adobe Acrobat files, you must have a copy of Adobe Reader. You can download it for free.